Table 2.
Variable | Vitamin D>50 nmol/L | Vitamin D≤50 nmol/L | P Value | β Coefficienta | P Value |
---|---|---|---|---|---|
Baseline fungal burden, log10 CFU/mL | 5.0 (4.6–5.3) | 5.1 (4.8–5.3) | .687 | 0.07 (−.32 to .47) | .702 |
CSF lymphocytes, ×106/Lb | 19 (1–67) | 15 (1–88) | .896 | −39 (−93 to 14) | .148 |
CSF TNF-α, log10 pg/mL | 0.81 (.70–.92) | 0.84 (.76–0.92) | .697 | −0.09 (−.21 to .03) | .148 |
CSF IFN-γ, log10 pg/mL | 1.61 (1.41–1.81) | 1.62 (1.49–1.74) | .988 | −0.09 (−.30 to .11) | .374 |
CSF IL-6, log10 pg/mL | 2.28 (1.84–2.72) | 2.43 (2.19–2.69) | .540 | −0.26 (−.68 to .17) | .231 |
CSF sCD14, log10 pg/mL | 6.02 (5.91–6.11) | 6.02 (5.97–6.09) | .834 | 0.03 (−.07 to .12) | .596 |
CSF neopterin, log10 pg/mL | 1.85 (1.75–1.95) | 1.90 (1.82–1.95) | .522 | −0.05 (−.16 to .06) | .366 |
CSF IFN-γ:sCD14 ratio | 0.25 (.21–.29) | 0.26 (.23–.28) | .788 | −0.02 (−.05 to .02) | .309 |
CSF IFN-γ:neopterin ratio | 0.82 (.68–.97) | 0.82 (.74–.90) | .914 | −0.04 (−.17 to .08) | .497 |
Early fungicidal activity, log10 CFU/mL/d | −0.56 (−0.46 to −0.66) | −0.56 (−.51 to −0.60) | .847 | −0.02 (−.09 to .06) | .701 |
Data are presented as means and 95% confidence intervals for the vitamin D–deficient and vitamin D–nondeficient groups.
Abbreviations: CFU, colony-forming units; CSF, cerebrospinal fluid; IFN, interferon; IL, interleukin; sCD14, soluble CD14; TNF, tumor necrosis factor; vitamin D, 25-hydroxyvitamin D.
a The β coefficients are from linear regression analyses where the clinical and immunological parameters were considered individually as dependent variables, and 25-hydroxyvitamin D levels (log transformed) were considered as the explanatory variable. The coefficients shown thus represent the average increase in the dependent variable for each single unit increase (log10 nmol/L) in 25-hydroxyvitamin D concentration.
b Heavily positively skewed; median values with interquartile ranges are shown.